Inventor · disambiguated record
David Keith Lyon
Also filed as: LYON DAVID K · LYON DAVID KEITH
17 granted patents·19 pending applications·297 citations·filing 1996–2023
94Inventor score
Top patents by PatentIndex Score
36 records- 0195US6984403B2Azithromycin dosage forms with reduced side effectsPFIZER·Filed 2004·Granted Jan 10, 2006·85 cites·48 claims
- 0295US6136222ALiquid absorbent solutions for separating nitrogen from natural gasBEND RES INC·Filed 1996·Granted Oct 24, 2000·113 cites·14 claims
- 0393US8940800B2Pharmaceutical compositions with enhanced performanceBABCOCK WALTER C·Filed 2012·Granted Jan 27, 2015·21 cites·10 claims
- 0490US8207232B2Pharmaceutical compositions with enhanced performanceBABCOCK WALTER C·Filed 2005·Granted Jun 26, 2012·13 cites·9 claims
- 0589US8372836B2Spray dried formulationBEND RES INC·Filed 2007·Granted Feb 12, 2013·8 cites·7 claims
- 0685US7887844B2Multiparticulate crystalline drug compositions having controlled release profilesPFIZER·Filed 2004·Granted Feb 15, 2011·16 cites·15 claims
- 0785US7625507B2Extrusion process for forming chemically stable drug multiparticulatesPFIZER·Filed 2004·Granted Dec 1, 2009·17 cites·19 claims
- 0878US8828438B2Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors and HMG-CoA reductaseFRIESEN DWAYNE THOMAS·Filed 2006·Granted Sep 9, 2014·2 cites·9 claims
- 0976US6077457ALiquid absorbent solutions for separating nitrogen from natural gasBEND RES INC·Filed 1998·Granted Jun 20, 2000·16 cites·15 claims
- 1075US9918997B2Compositions and methods for the treatment of neurodegenerative and other diseasesREEDER THADDEUS CROMWELL·Filed 2017·Granted Mar 20, 2018·1 cites·11 claims
- 1170US2010003331A1Sustained release dosage forms of ziprasidonePFIZER·Filed 2009·Application pending·0 cites
- 1267US11559488B2Pharmaceutical compositions having high drug loadings of medium chain triglycerides and methods related theretoCERECIN INC·Filed 2018·Granted Jan 24, 2023·1 cites·25 claims
- 1367US8834929B2Drying of drug-containing particlesDOBRY DANIEL ELMONT·Filed 2007·Granted Sep 16, 2014·2 cites·11 claims
- 1464US9980978B2Compositions and methods for the treatment of neurodegenerative and other diseasesGLIALOGIX INC·Filed 2016·Granted May 29, 2018·0 cites·3 claims
- 1564US9974798B2Compositions and methods for the treatment of neurodegenerative and other diseasesGLIALOGIX INC·Filed 2016·Granted May 22, 2018·0 cites·8 claims
- 1663US10398713B2Compositions and methods for the treatment of neurodegenerative and other diseasesGLIALOGIX INC·Filed 2018·Granted Sep 3, 2019·0 cites·11 claims
- 1762US7897175B2Dosage forms comprising a CETP inhibitors and an HMG-CoA reductase inhibitorBEND RES INC·Filed 2003·Granted Mar 1, 2011·2 cites·13 claims
- 1861US9597339B2Compositions and methods for the treatment of neurodegenerative and other diseasesGLIALOGIX INC·Filed 2014·Granted Mar 21, 2017·0 cites·4 claims
- 1960US2008015343A1Azithromycin dosage forms with reduced side effectsPFIZER·Filed 2007·Application pending·0 cites
- 2060US2007190129A1Sustained release dosage forms of ziprasidonePFIZER·Filed 2004·Application pending·0 cites
- 2157US2005152982A1Controlled release multiparticulates formed with dissolution enhancersPFIZER·Filed 2004·Application pending·0 cites
- 2257US2005123616A1Azithromycin multiparticulate dosage forms by liquid-based processesPFIZER·Filed 2004·Application pending·0 cites
- 2357US2005158391A1Azithromycin multiparticulate dosage forms by melt-congeal processesPFIZER·Filed 2004·Application pending·0 cites
- 2456US2006029677A1Azithromycin dosage forms with reduced side effectsPFIZER·Filed 2005·Application pending·0 cites
- 2556US2006039988A1Azithromycin dosage forms with reduced side effectsPFIZER·Filed 2005·Application pending·0 cites
- 2656US2020009118A1Compositions and methods for the treatmentof neurodegenerative and other diseasesGLIALOGIX INC·Filed 2019·Application pending·0 cites
- 2756US2023277459A1Pharmaceutical compositions having high drug loadings of medium chain triglycerides and methods related theretoCERECIN INC·Filed 2023·Application pending·0 cites
- 2853US2008199527A1Enteric Coated Azithromycin MultiparticulatesPFIZER·Filed 2005·Application pending·0 cites
- 2951US2004185102A1Dosage forms comprising a CETP inhibitor and an HMG-CoA reductase inhibitorPFIZER·Filed 2003·Application pending·0 cites
- 3051US2008075784A1Taste Making Formulation Comprising The Drug In A Dissolution-Retarded Form And/Or Cyclodextrin In A Dissolution-Enhanced FormPFIZER·Filed 2005·Application pending·0 cites
- 3149US2018110760A1Compositions and methods for the treatmentof neurodegenerative and other diseasesGLIALOGIX INC·Filed 2017·Application pending·0 cites
- 3248US2011002989A1Methods, dosage forms and kits for administering ziprasidone without foodPFIZER·Filed 2009·Application pending·0 cites
- 3348US2005129772A1Compositions comprising an HIV protease inhibitorAGOURON PHARMA·Filed 2004·Application pending·0 cites
- 3445US2009142401A1Multiparticulates comprising low-solubility drugs and carriers that result in rapid drug releaseAPPEL LEAH ELIZABETH·Filed 2006·Application pending·0 cites
- 3538US2011027372A1Multiparticulates comprising low-solubility drugs and carriers that result in rapid drug releaseAPPEL LEAH ELIZABETH·Filed 2010·Application pending·0 cites
- 3637US2021186915A1Pharmaceutical compositions having high drug loadings of medium chain triglycerides and methods related theretoCERECIN INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David Keith Lyon files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →